Efficacy of adepress (paroxetin) in generalized anxiety disorder

被引：0

作者：

Chakhava, V. O. ^{[1
]}

Budtueva, F. S. ^{[1
]}

Borukaev, R. R. ^{[1
]}

机构：

[1] Serbsky Natl Res Ctr Social & Forens Psychiat, Moscow, Russia

来源：

ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2010年 / 110卷 / 08期

关键词：

generalized anxiety disorder; somatic anxiety; cognitive anxiety; treatment; adepress (paroxetin); IMIPRAMINE; TRIAL;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The aim of the study was to evaluate efficacy of adepress (paroxetin) in different clinical variants of generalized anxiety disorder (GAD). Adepress was used as a monotherapy during 42 days. Patient's state was assessed using Hamilton anxiety scale (HAM-A) at baseline and every week thereafter. The study included 49 patients aged 36,2 8,2 years. Patients were stratified into two groups according to the predominance of somatic (24 cases) or cognitive (21 cases) anxiety. The efficacy of adepress was shown both in a separate GAD and in a GAD with comorbid psychopathology. The effect of the drug was seen in patients with somatic anxiety after 3-4 weeks and in patients with cognitive anxiety after 3-6 weeks.

引用

页码：25 / 29

页数：5

共 19 条

[11] DELINEATION OF 2 DRUG-RESPONSIVE ANXIETY SYNDROMES [J].

KLEIN, DF .

PSYCHOPHARMACOLOGIA, 1964, 5 (06) :397-408

[12]

LESS YUE, 2008, ROS PSIKHIAT ZHURN, V2, P40

[13]

MOSOLOV SN, 1995, KLINICHESKOYE PRIMEN

[14]

MOSOLOV SN, 1996, OSNOVY PSIKHOFARMAKO

[15]

MOSOLOV SN, 2005, PSIKHIAT PSIKHOFARMA, V7, P3

[16]

RAJ A, 2002, GEN ANXIETY DISORDER, P137

[17]

RICKELS K, 1993, ARCH GEN PSYCHIAT, V50, P884

[18] Paroxetine efficacy in the treatment of generalized anxiety disorder [J].

Rocca, P ;

Fonzo, V ;

Scotta, M ;

Zanalda, E ;

Ravizza, L .

ACTA PSYCHIATRICA SCANDINAVICA, 1997, 95 (05) :444-450

[19]

SMULEVICH AB, 2002, CONSILIUM MEDICUM, P3

← 1 2 →